1 – 7 of 7
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
FragMAX Facility for Crystallographic Fragment and Ligand Screening at MAX IV
- Contribution to journal › Article
-
Mark
Status and perspective of protein crystallography at the first multi-bend achromat based synchrotron MAX IV
- Contribution to journal › Article
-
Mark
Structural basis for small molecule binding to the SARS-CoV-2 nsp10–nsp14 ExoN complex
- Contribution to journal › Article
- 2023
-
Mark
Allosteric regulation and crystallographic fragment screening of SARS-CoV-2 NSP15 endoribonuclease
- Contribution to journal › Article
- 2022
-
Mark
Of problems and opportunities—How to treat and how to not treat crystallographic fragment screening data
- Contribution to journal › Letter
-
Mark
Experiences From Developing Software for Large X-Ray Crystallography-Driven Protein-Ligand Studies
- Contribution to journal › Article
- 2021
-
Mark
Identification of fragments binding to SARS-CoV-2 nsp10 reveals ligand-binding sites in conserved interfaces between nsp10 and nsp14/nsp16
- Contribution to journal › Article
